baber/WOPTO huggingface dataset:
Patent AT-E314011-T1 (AT)
Inventor: NOBLES ANTHONY A
IPC: A61B17/00
Filed: 1998-05-18
Granted: 2006-01-15
Abstract: A device (9) is disclosed for partially occluding a blood vessel such that an area of hemostasis within the blood vessel is created without interrupting the blood flow through the blood vessel. The device is particularly suited for performing a cardiac bypass procedure without the need to stop the patient's heart. The device comprises first and second partially occlusive portions (12, 14), spaced apart from one another, wherein the partially occlusive portions are inflatable to at least the inner diameter of the blood vessel. A tubular member (16) interconnects the first and second partially occlusive portions (12, 14) and forms a conduit which allows the blood to flow through. When the first and second partially occlusive portions (12, 14) are inflated, an area of hemostasis is created between an outer surface of the tubular member (16) and an inner wall of the blood vessel while blood continues to flow through the tubular portion. A tube (20) adapted to extend through an opening in the blood vessel to deploy the device includes multiple lumens, such as an inflation lumen (17) to inflate the device and a suture lumen (19) to collapse the device.
Patent AT-E212139-T1 (AT)
Inventor: HAGN THOMAS
IPC: G06K17/00
Filed: 1998-05-15
Granted: 2002-02-15
Abstract: Procedures for the performance of electronic chip-card personalization and/or initialization and/or a chip-card application, characterized by the following procedural steps: contacting the chip card by a first device; setting up or providing a connection between the first device and a separate second device designed to establish a logical communication link to provide for communication between the chip card and the second device via the first device; requesting the performance of chip-card personalization and/or initialization and/or a chip-card application, with the request directed to the first device by the second device; and performing the requested chip-card personalization and/or initialization and/or the requested chip-card application by way of a transparent transfer of data and/or commands back and forth between chip card and second device via the logical communication link.
Patent AT-E261293-T1 (AT)
Inventor: MARTIN BERTRAND
IPC: A61M21/02
Filed: 1998-10-12
Granted: 2004-03-15
Abstract: The invention concerns an apparatus for inducing deep physical and mental relaxation, consisting of a housing containing both a collector (4) and a reservoir (5) wherein are housed a pump (1) and a thermostat heater (2). The liquid contained in the reservoir can be maintained at constant temperature and pumped by a tube (6) to flow onto the patient's forehead whose head rests on the collector. The invention also concerns two other embodiments.
Patent AT-E245311-T1 (AT)
Inventor: CISAR ALAN J
IPC: H01M4/86
Filed: 1998-09-10
Granted: 2003-08-15
Abstract: A fuel cell design for use at low pressure. The invention has a reduced number of component parts to reduce fabrication costs, as well as a simpler design that permits the size of the system to be reduced at the same time as performance is being improved. In the present design, an adjacent anode and cathode pair are fabricated using a common conductive element, with that conductive element serving to conduct the current from one cell to the adjacent one. This produces a small and simple system suitable for operating with gas fuels or alternatively directly with liquid fuels, such as methanol, dimethoxymethane, or trimethoxymethane. The use of these liquid fuels permits the storage of more energy in less volume while at the same time eliminating the need for handling compressed gases which further simplifies the fuel cell system. The electrical power output of the design of this invention can be further increased by adding a passage for cooling the stack through contact with a coolant. In particular the invention relates to a low pressure gas electrode, comprising an electrically conducting substrate wherein the substrate comprises at least two opposite faces; a plurality of openings allowing passage from one face to an opposite face, wherein the openings encompass between about 10% and about 90% of the total area of the substrate and an electrically conductive porous material bound to the substrate comprised of a electrically conductive component and a binding component.
Patent AT-E252539-T1 (AT)
Inventor: JEROMIN LUTZ
IPC: C07B61/00
Filed: 1998-12-10
Granted: 2003-11-15
Abstract: The invention discloses a process for the production of monoglycerides by glycerolysis of methyl ester derived from animal or vegetable fat and oils which includes mixing a surplus of 0.1 to 3 moles of glycerols in relation to methyl ester, subjecting the reaction mixture to a reaction temperature between 130 to 160 at a vacuum of 200 to 400 mbar, adding of alkaline catalysts, stopping the reaction by fast cooling of the reaction mixture and the destruction of the alkaline catalyst when the quantity of glycerides has reached a concentration of mono and diglyceride of 40 to 60 %, leaving the catalyst in the reaction mixture to catalyse the reaction downstream in a reactor, separating the surplus methyl ester and glycerol by distillation and stopping the reaction by fast cooling of the reaction mixture with reactor and the destruction of the alkaline catalyst when the quantity of glycerides has reached a concentration of 40 to 60 % and the ratio of concentrations of mono and diglyceride lies between 3 to 10.
Patent AT-E237953-T1 (AT)
Inventor: GISAW YONAS
IPC: A23L1/164
Filed: 1998-12-30
Granted: 2003-05-15
Abstract: Fabricated snacks produced from doughs comprising (1) a potato-based flour component, (2) one or more polysaccharides selected from the group consisting of non-potato-based flour, starch, gum, or mixtures thereof, and (3) water are disclosed. The doughs are cohesive, non-adhesive, and sheetable, and the fabricated snacks produced therefrom have desired expansion, crispness, and mouthmelt.
Patent AT-E230896-T1 (AT)
Inventor: CHEVASSUS-MORE ALAIN
IPC: F16B21/06
Filed: 1999-10-04
Granted: 2003-01-15
Abstract: The invention is a clip (1) for the placing in contact with, and the retention of a contact pin within an opening (2) in a conductor (3) manufactured in the form of a sheet or board. This clip includes a cylindrical sleeve (4) possessing, at at least one of its ends, shoulders (5) for fitting against the edge of the opening or against an intervening component. According to the invention, the sleeve (4) has at at least one of its ends a number of open slots (6) extending parallel to its main axis, the end of the sleeve at said end projecting above the surrounding surface and possessing a profile in the form of truncated cone creating an abutment (7) enabling the sleeve to fit into a corresponding annular groove (9) made in the surface of a backing ring (8). <IMAGE>
Patent AT-E227763-T1 (AT)
Inventor: FIEBACK KLAUS
IPC: C09K5/06
Filed: 1999-03-18
Granted: 2002-11-15
Abstract: The invention relates to a microwave-activated latent heat accumulator body (1, 17, 28, 30, 31, 32) with a paraffin-based latent heat accumulator material (6). The aim of the invention is to provide a device of this type which is simple to produce and which has advantageous properties for use. To this end, the inventive latent heat accumulator body contains a hygroscopic material.
Patent AT-E542885-T1 (AT)
Inventor: RICHARDS DAVID
IPC: C12N1/10
Filed: 1999-03-30
Granted: 2012-02-15
Abstract: Vaccines for the prevention and/or treatment of Eimeria infection including one or more strains of E. maxima ARI-73/97, E. acervulina ARI-77/97, E. tenella ARI-11/98, E. necatrix MCK01 and/or E. necatrix ARI-MEDNEC<SUB>3</SUB>+8 are described. Eimeria selected from E. maxima ARI-73/97, E. acervuina ARI-77/97, E. tenella ARI-11/98, E. necatrix MCK01 and/or E. mecatrix ARI-MEDNEC<SUB>3</SUB>+8 are also described.
Patent AT-E247277-T1 (AT)
Inventor: MARTINEZ OLIVAS BENJAMIN
IPC: G01K1/02
Filed: 1999-05-12
Granted: 2003-08-15
Abstract: A wireless telematic thermometer for remote measurement of a human or animal body on the basis of information transmitted by a transmitting module and received by a receiving module, in which the temperature evaluation is carried out in the receiving module, the transmitting module having a probe that is permanently in contact with the body, for obtaining digital sequences which are periodically sent to the receiver, with the co-operation of a transistor controlled by a microprocessor. The receiver has receiving means associated with a microprocessor which controls movement recorders for displaying the information on a viewing screen; it also has acoustic and luminous warning means.  <IMAGE>
Patent AT-E498354-T1 (AT)
Inventor: GOLDEN BRUCE
IPC: A61B3/12
Filed: 1999-07-07
Granted: 2011-03-15
Abstract: The present invention creates a permanent record of an animal through a series of steps including, preliminarily acquiring an image of the retinal vasculature of the animal of interest; digitizing that image if the image is not a digital image; analyzing the image to determine if the image is satisfactory for further analysis; storing the image; and analyzing the image for unique anatomical landmarks. The image and data gathered therefrom may be stored in a database for later retrieval and comparison against other images. The data gathered from the image may be compared against other stored data in the database to determine the identity of the animal. Preferably, the system would also include a global positioning system ("GPS") device which would simultaneously time and date stamp the acquired image as well as stamp the image with the location where the imaging took place by recording the latitude and longitude of that location.
Patent AT-E338965-T1 (AT)
Inventor: THOMPSON ROBERT I DI
IPC: G02B5/30
Filed: 1999-07-09
Granted: 2006-09-15
Abstract: A polyhalide tight-polarizing material comprising a complex obtained by reacting: (a) elemental iodine; (b) a hydrohalide acid or an ammonium halide, alkali metal halide or alkaline earth metal halide; (c) a first compound capable of chelating hydrogen, ammonium or metal ions; and (d) a second compound comprising at least one chelating group present in the first compound and either (1) at least one group of the first compound is changed to a different group or (2) the second compound comprises at least one additional group.
Patent AT-E315403-T1 (AT)
Inventor: KAPIKIAN ALBERT Z
IPC: A61P31/14
Filed: 1999-07-27
Granted: 2006-02-15
Abstract: The present invention provides vaccine compositions for protection against human rotaviral disease without significant reactogenicity. Human×bovine reassortant rotavirus comprising each of the four clinically most important VP7 serotypes of human rotavirus are combined in a multivalent formulation which provides a high degree of infectivity and immunogenicity without producing a transient febrile condition. Methods for producing an immunogenic response without producing a transient febrile condition are also provided.
Patent AT-E228190-T1 (AT)
Inventor: RUEEGGER RUDOLF
IPC: E02D29/02
Filed: 1999-09-15
Granted: 2002-12-15
Abstract: According to the inventive method, a steep front (2) is anchored in the soil (1) using front elements (3). Said front elements consist of angular support grids (6) each comprising a front grid element (7) upwardly oriented and a substantially horizontal bottom grid element (8). Together, the front grid elements (7) form a grid system which is congruent with the front (2). The bottom grid elements (8) extend from the front (2) into the soil construction. One front element (3) which is arranged parallel to the front grid element (7) is provided with an intermediate grid (9) which is fastened to said front element (3) by means of holding members (10). A cavity (14) between the front grid element (7) and the intermediate grid (9) is filled with coarse filling material (15) such as gravel or pebble stones. At least one backfill cavity (16) is filled with any desired bulk material (17) on the side of the intermediate grid (9) facing away from the front grid element (7). The invention especially provides a means for producing supporting structures and revetments.
Patent AT-E205992-T1 (AT)
Inventor: HUTZELMANN HOLGER
IPC: H04N7/26
Filed: 1999-01-14
Granted: 2001-10-15
Abstract: A communication network comprises a first network which permits data to be transmitted at a first bit rate and a second network which permits data to be transmitted at a second bit rate. A first terminal comprises an encoder which can generate a scaled data flow with at least two data layers from a signal to be coded. The data layers differ in their information content as regards the signal to be coded and the scaled data flow has a bit rate which is smaller than or equal to the first bit rate. A decoder is located in a second terminal and can decode a received data flow. The first and the second network are linked by a network connecting unit which can be operated so as to modify the received data flow by removing at least one data layer in such a way that the modified scaled data flow has a modified bit rate which is smaller than or equal to the second bit rate, and so as to feed the modified scaled data flow into the second network.
Patent AT-E224095-T1 (AT)
Inventor: DOLINSEK MIRAN
IPC: H01H71/00
Filed: 1999-10-14
Granted: 2002-09-15
Abstract: A wall of a seat (10) surrounding a fuse (11) is provided with a first and second guiding slot (31, 30), adjacent to each other at a first end of the seat (10), and a third guiding slot (32) at a second end of the seat (10), all transversal to the seat axis. In the first guiding slot (31) an electrically conducting intermediate plate (22) and in the second guiding slot (30) a bow spring (21) and in the third guiding slot (32) a size controlling bow insert (23) are engagably inserted. In the state of closed contacts, the intermediate plate (22) electrically contacts the down conductor contact (14), which is, through an insulating partition (15), completely electrically insulated from the surroundings. The bow spring (21) is elastically spreadable on both ends. The improved fuse seat makes possible a simple replacement of fuses of various dimensions and prevents a dropping of the fuses out of a magazine, the down conductor contact, however, is completely protected against being touched.
Patent AT-E273961-T1 (AT)
Inventor: CLAVEL JEAN-LOUIS
IPC: C07D231/38
Filed: 1999-10-22
Granted: 2004-09-15
Abstract: A process for the preparation of a compound of formula (I) comprising oxidizing a compound of formula (II) with trifluoroperacetic acid in the presence of a corrosion inhibiting compound such as boric acid. Also, a process for preparing a compound of formula (II) by adding sulfur dioxide to a mixture of the corresponding disulfide, a formate salt, trifluoromethyl bromide and a polar solvent; and a process for preparing the disulfide comprising adding S<SUB>2</SUB>Cl<SUB>2 </SUB>to a solution, in an organic solvent, of the corresponding 4-unsubstituted pyrazole.
Patent AT-E283849-T1 (AT)
Inventor: TAOKA NAOAKI
IPC: C07D309/30
Filed: 1999-12-10
Granted: 2004-12-15
Abstract: This invention provides an easy and efficient process for producing a simvastatin of great use as an HMG-CoA reductase inhibitor, which comprises deacylation of lovastatin with an inorganic base and a secondary or tertiary alcohol and subjecting the resulting did lactone to selective protection with a ketal or acetal protective group, acylation and deprotection-lactonization to give simvastatin.
Patent AT-E246889-T1 (AT)
Inventor: CIONCADA ENRICO
IPC: A47C1/032
Filed: 1999-09-22
Granted: 2003-08-15
Abstract: A chair with variable pitch having a frame set to rest on the floor, at least one central element that creates a substantially horizontal longitudinal axis supported by the frame, a seat supported by the central element, one pair of first stiles parallel to each other and set at the ends of the central element, and a backrest that has its top connected to the first stiles through first flexible couplings and its bottom connected to the seat through a second flexible coupling. The seat is connected to the central element through swivel means that allow the planar rotary-transverse movement of the seat, combined with a rotary rocking movement of the backrest around a longitudinal axis created by the flexible couplings.
Patent DE-18709683-T1 (DE)
Title: Verbundene aufzeichnungsmediumplatte
Inventor: DE MAGNIENVILLE SYLVIN
IPC: G06K19/077
Filed: 2018-02-22
Abstract: Analoge Aufzeichnungsträgerplatte (10) mit mindestens einer ersten Fläche (12), die mindestens eine Ausleseschicht (14) und mindestens ein erstes Etikett (22) aufweist, dadurch gekennzeichnet, dass sie mindestens eine Radioerkerkennungseinrichtung (32) aufweist, wobei die Radioerkennungseinrichtung (32) mindestens einen kontaktlosen Mikrochip (34) aufweist, der einer Antenne (36) zugeordnet ist, wobei die Antenne (36) direkt auf einer Fläche (26) des Etiketts (22) aufgedruckt ist und dieses Etikett in dem die Platte bildenden Material aufgenommen ist.
Patent DE-573603-T1 (DE)
Inventor: LEY ARTHUR
IPC: C40B40/02
Filed: 1992-02-28
Abstract: The present invention relates to non-naturally occurring proteins which inhibit human neutrophile elastase, which proteins comprise at least the core sequence of a Kunitz domain. Other aspects of the invention relate to pharmaceutical compositions comprising these proteins, and the use of these proteins or compositions for use in medicine, in particular for the preparation of medicaments for the treatment of disorders or diseases associated with excessive human neutrophile elastase activity.
Patent DE-1073432-T1 (DE)
Inventor: TSAI GUOCHUAN
IPC: A61K31/198
Filed: 1999-04-14
Abstract: A pharmaceutical composition comprising (i) at least one agonist of the glycine site of an NMDA receptor and (ii) a second therapeutic agent which is a antipsychotic, antidepressant, psychostimulants or Alzheimer's disease therapeutic. The agonist is D-alanine, a salt of D-alanine, an ester of D-alanine, alkylated D-alanine, a precursor of D-alanine, D-serine, a salt of D-serine, an ester of D-serine, alkylated D-serine, a precursor of D-serine, D-cycloserine, a salt of D-cycloserine, an ester of D-cycloserine, a precursor of D-cycloserine, or alkylated D-cycloserine. The pharmaceutical composition is substantially free of D-cycloserine when the agonist is D-alanine, a salt of D-alanine, an ester of D-alanine, an alkylated D-alanine, or a precursor of D-alanine. Where the agonist is D-cycloserine, a salt of D-cycloserine, an ester of D-cycloserine, a precursor of D-cycloserine, or alkylated D-cycloserine, the pharmaceutical composition comprises an amount of the agonist equivalent to 105-500 mg of D-cycloserine.
Patent CY-1107457-T1 (CY)
Title: Εμβoλιο κατa του hpv
Inventor: SLAOUI MONCEF MOHAMMED
IPC: E02D3/11
Filed: 2006-02-01
Abstract: Εμβόλια που αποτελούνται από HPV 16 L1 VLP, HPV 18 L1 VLP και τον συνδυασμό αμφοτέρων με υδροξείδιο του αργιλίου και 3D MPL.
Patent CY-1114598-T1 (CY)
Inventor: Räthe Ingmar
IPC: C12Q1/70
Filed: 2008-07-23
Abstract: The present invention relates to a method for the cultivation of primary cells. The primary cells are cultivated in a serum free medium comprising a factor selected from the group consisting of growth factors and attachment factors. The method for the cultivation of primary cells may be one step in a method for the amplification of viruses, such as poxviruses. According to this latter method the primary cells are cultivated in a serum free medium comprising a factor selected from the group consisting of growth factors and attachment factors. The cells are then infected with the virus and the infected cells are cultivated in serum free medium until progeny virus is produced.
Patent CY-1108818-T1 (CY)
Inventor: RAMASWAMY SOWMIANARAYANAN
IPC: C07B61/00
Filed: 2009-02-26
Abstract: A process for preparing  d-threo  methyl ±- piperid-2-ylarylacetates of formula III:   
wherein R 1  is aryl having 6 to 28 carbon atoms, comprising the steps of:  reacting a pyridine having formula I:     
wherein R 1  is aryl having 6 to 28 carbon atoms with hydrogen in an alkanoic acid having 1 to 10 carbon atoms and in the presence of a catalyst to provide a mixture of  threo  and  erythro  piperidine stereoisomers having formulas IIa-d:      
adding an alkyl alkanoate having 2 to 20 carbon atoms to said mixture, thereby precipitating alkanoate salts of said  erythro  stereoisomers preferentially with respect to alkanoate salts of said  threo  stereoisomers; 
reacting said  erythro  alkanoate salts with aqueous base to form said  erythro  stereoisomers; 
reacting said  erythro  stereoisomers with an acid resolving agent in an alkyl alcohol having 1 to 5 carbon atoms, thereby forming acid salts of said  1-erythro  stereoisomers preferentially with respect to said  d-erythro  stereoisomers; 
reacting said  1-erythro  acid salts with aqueous base to form said  1-erythro  piperidine; 
reacting said  1-erythro  piperidine with an alkali metal alkoxide having one to 10 carbon atoms in organic solvent, whereby forming said  d-threo  piperidine, and 
converting said  d-threo  piperidine to said  d-threo  methyl ±- piperid -2- ylarylacetate.
Patent CY-1109067-T1 (CY)
Title: Μετρηση ουσιων σε υγρα
Inventor: DAVIES OLIVER WH
IPC: C12Q1/54
Filed: 2009-05-14
Abstract: Σε μίαν μέθοδο μέτρησης της πυκνότητας μίας ουσίας όπως γλυκόζης σε ένα δείγμα υγρού όπως αίματος ή διάμεσου υγρού, παρέχεται μία συσκευή μέτρησης έχουσα ένα τμήμα αισθητήρα εργασίας (6b), ένα δεύτερο τμήμα αισθητήρα εργασίας (8b) και ένα τμήμα αισθητήρα αναφοράς (4b). Το δείγμα υγρού τοποθετείται στην συσκευή μέτρησης και ένα ηλεκτρικό ρεύμα ανάλογο προς την πυκνότητα της ουσίας στο δείγμα υγρού μετράται σε έκαστο τμήμα αισθητήρα (6b, 8b). Τα ηλεκτρικά ρεύματα συγκρίνονται προς εξακρίβωση της διαφοράς. Εάν η διαφορά είναι μεγαλύτερη από ένα προκαθορισμένο κατώφλιο, δίδεται μία ένδειξη σφάλματος. Μία ταινία δοκιμής μίας χρήσεως με δύο αισθητήρες εργασίας (6b, 8b) επίσης αποκαλύπτεται.
Patent CY-1113062-T1 (CY)
Inventor: SINGH HARPREET
IPC: C12P21/00
Filed: 2011-03-11
Abstract: The present invention relates to immunotherapeutic methods, and molecules and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides, that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the present invention relates to two novel peptide sequences derived from HLA class II molecules of human tumour cell lines which can be used in vaccine compositions for eliciting anti-tumour immune responses.